Phase I: Relapsed or Refractory B-cell Malignancies
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB11703 | Acalabrutinib | 1 / 2 | Active Not Recruiting | 1 |
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB11703 | Acalabrutinib | 1 / 2 | Active Not Recruiting | 1 |